Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Karima I. El-Desouky"'
Publikováno v:
Journal of Immunoassay and Immunochemistry. 43:192-212
Developing the prognostic aspects of endometrial carcinoma through shedding light on immune check point proteins (PD-L1 and CTLA-4) together with Tumor-Infiltrating Lymphocytes (TILs) may help finding new targets for immunotherapy, especially for adv
Publikováno v:
The Medical Journal of Cairo University. 87:1439-1448
Background: Vitiligo is an acquired pigmentary disorder of unknown etiology that affects up to 1% of the general population of all skin types.It is a multifactorial disorder. There are numerous medical and surgical treatments aimed at repigmentation.
Publikováno v:
British Journal of Pharmaceutical Research. 12:1-11
Publikováno v:
Journal of Immunotoxicology. 13:393-402
The current study investigated the combinatorial effect of pravastatin (PRAV) and bone marrow mononuclear cells (BM-MNC) on acute myocardial infarction (AMI) induced experimentally in rats. After induction of MI, rats were given oral PRAV (20 mg/kg/d
Publikováno v:
Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia. 151(5)
The aim of this paper was to study immunohistochemical expression of discoidin domain receptor 1 (DDR1) in lesional and non-lesional skin of vitiligo patients in comparison to controls, to explore its possible implication vitiligo pathogenesis.Twenty
Publikováno v:
Journal of immunotoxicology. 10(1)
Histamine, involved in many inflammatory reactions and immune responses, is reported to suppress--via H4R stimulation--injury concomitant with the late phase of warm hepatic ischemia/re-perfusion (I/R). The current study investigated the possible eff
Publikováno v:
Research in Pharmaceutical Biotechnology. 4
Several studies have shown that peroxisome proliferator-activated receptor-g (PPARg) agonists protect against ischemia/re-perfusion (I/R) damage in different organs. This study was carried out to assess the possible role of PPARg on intestinal I/R-me